ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.42
-0.56%
US Tech 100
18,088.41
0.33%
S&P 500
5,273.58
-0.07%
US Dollar vs CAD
1.36205
-0.23%
Bitcoin
69,276.15
2.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Spruce Biosciences Inc (SPRB)

  7. Spruce Biosciences Inc (SPRB) News

SPRB

Spruce Biosciences (SPRB)

Spruce Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SPRB
DateTimeSourceHeadlineSymbolCompany
06/03/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
06/03/20246:00AMBusiness WireSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024NASDAQ:SPRBSpruce Biosciences Inc
05/24/20243:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
05/24/20243:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
05/24/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
05/24/20243:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
05/24/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
05/23/20243:05PMBusiness WireSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
05/22/20243:14PMBusiness WireSpruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine SocietyNASDAQ:SPRBSpruce Biosciences Inc
05/13/20243:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
05/13/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
05/13/20243:01PMBusiness WireSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
05/01/20243:05PMBusiness WireSpruce Biosciences to Participate in May Investor ConferencesNASDAQ:SPRBSpruce Biosciences Inc
04/30/20243:05PMBusiness WireSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
04/22/20243:05PMBusiness WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
03/13/20243:08PMBusiness WireSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
03/13/20243:01PMBusiness WireSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
03/07/20243:07PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
02/06/20243:15PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
01/30/20243:05PMBusiness WireSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SPRBSpruce Biosciences Inc
01/22/20247:00AMBusiness WireSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
01/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
01/05/20247:00AMBusiness WireSpruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
01/04/20247:00AMBusiness WireSpruce Biosciences Provides Clinical Program Updates and Outlook for 2024NASDAQ:SPRBSpruce Biosciences Inc
01/03/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
12/18/20237:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
12/18/20237:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
11/28/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
11/13/20233:22PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
11/13/20233:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SPRB

Your Recent History

BIT
UIG246
Unicredit Bank
ASX
GNX
Genex Power
BIT
SGAS3L
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved